Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model-Reference-Cited by-同舟云学术

Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model

Published:2016-08-21 Issue:10 Volume:56 Page:2618-2626
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Bonhomme Fanny¹,Godier Anne²³,Samama Charles Marc³⁴,Lecompte Thomas⁵⁶,Fontana Pierre⁶⁷

Affiliation:

1. Department of Anesthesiology; Pharmacology, and Intensive Care, Geneva University Hospitals; Geneva Switzerland

2. Department of Anesthesiology and Intensive Care Medicine; Fondation Opthalmologique Adolphe de Rothschild

3. Faculté de Pharmacie; INSERM UMR-S1140, Université Paris Descartes

4. Department of Anesthesiology and Intensive Care Medicine; Department of Anesthesiology and Intensive Care Medicine, Cochin University Hospital, Assistance Publique-Hopitaux de Paris, Université Paris Descartes; Paris France

5. Division of Haematology; Geneva University Hospitals

6. Geneva Platelet Group, Faculty of Medicine, University of Geneva

7. Division of Angiology and Haemostasis; Geneva University Hospitals; Geneva Switzerland

Funder

“Projets Recherche et Développement” from the Geneva University Hospitals and by the Department of Anesthesiology, Pharmacology, and Intensive Care, Geneva University Hospitals, Geneva, Switzerland

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13765/fullpdf

Reference38 articles.

1. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);Hamm;Eur Heart J,2011

2. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Steg;Eur Heart J,2012

3. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation Thrombolysis in Myocardial Infarction 44 Trial;Wiviott;Circulation,2007

4. Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation;Huang;Crit Pathw Cardiol,2012

5. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy;Tanguay;Can J Cardiol,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models;Science Translational Medicine;2019-02-13

2. Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding;European Journal of Anaesthesiology;2018-03

3. Erratum;Transfusion;2017-01